Amid a rise in Covid cases in several countries, official sources on Wednesday said that the Serum Institute of India (SII) has offered 20 million coronavirus vaccines, Covishield, free of cost to the central government.

Serum Institute of India to provide 20 mln Covishield vaccines worth $49.5 million to govt free of cost

Visiting Australian Trade Minister Dan Tehan has said that his country is "warmly looking forward" to welcoming back Indian students to the country as Canberra gives a nod to Covishield for international travellers.

Australia recognises Covishield vaccine: Looks forward to welcome Indian students

Soumya Swaminathan, the top scientist of the World Health Organization (WHO), announced on Friday that 15 European Union (EU) countries officially recognise Covishield, a vaccine developed by AstraZeneca and Oxford University and produced by the Serum Institute of India (SII).

COVID-19: 15 countries in European Union recognise India-made Covishield vaccine

European Union has excluded COVID-19 vaccine Covishield from its 'Green Pass' list. India has formally raised the issue with the EU. Adar Poonawalla, CEO of the Serum Institute, said he has taken this up at the “highest levels”.

India's Covishield vaccine excluded from European Union's 'green pass'

India's Covaxin has shown 77.8 per cent efficacy against coronavirus in phase 3 trial data in review by the subject expert committee, news agency ANI quoting sources reported on Tuesday.

Covaxin has shown 77.8 per cent efficacy against virus: Report

As India's vaccination drive kicks into high gear, catch the ground report from our correspondent Johan Castell as he visits one of India's largest vaccination centres and receives his first dose of the Covishield Coronavirus vaccine in New Delhi. Get to know what to expect and what the process looks like for those getting the jab.

Getting vaccinated for Coronavirus in India

The Union health ministry on Sunday clarified that already booked online appointments for the second dose of Covishield vaccine will remain valid and the same will not be cancelled on Co-WIN platform.

Already booked online appointments for 2nd Covishield dose to remain valid: Govt

A group of health workers in India’s northeastern state of Assam is being questioned about running a vaccine centre that is allegedly unauthorised. The vaccination centre was set up at Silchar civil hospital in Assam without completing and following the required process and the health workers had been charging nearly INR 2,000 for each dose.

India: Health workers administering Covishield at unauthorised vaccine centre busted

Amid a surge in coronavirus cases in India, the CEO of Serum Institute of India (SII) said it will reduce the price of the Covishield vaccine by INR 100. The price of the vaccine has been reduced from 400 rupees to 300 per dose for all Indian states, said an announcement by Adar Poonawalla on Wednesday.

After row, Serum Institute cuts price of its Covid vaccine to 300 rupees for states as 'philanthropic gesture'

The Indian government on Wednesday said 0.03 per cent of people tested positive for coronavirus after taking the second dose of Covishield, while 0.04 per cent contracted the virus after receiving the second jab of Covaxin.

0.03% contracted Covid-19 after receiving second jab of Covishield; 0.04% post Covaxin

Serum Institute of India (SII) said it will charge state governments at Rs 400 ($5.30) and private hospitals Rs 600 ($7.95) for one dose of its Covishield COVID-19 vaccine.

Serum Institute fixes Covishield vaccine prices: Rs 400 for govt hospitals, Rs 600 for private

Bhutan on Wednesday said it had given about 60 per cent of its entire population the first jab against Covid-19 since the Himalayan kingdom started an ambitious vaccination drive nine days ago.

Bhutan vaccinates 60% of the population with Covishield in record time

Nepal army received 100,000 doses of the coronavirus vaccine from their Indian counterparts in Kathmandu on Sunday. Nine packages of COVISHIELD vaccine, manufactured by Serum Institute of India, was received by Nepali army officials at the Kathmandu airport.

Nepal army receives 100,000 COVID-19 vaccine doses from India

India has said that it’s going ahead with administering the AstraZeneca vaccine as it has seen no signs that the vaccine causes blood clots in recipients. Watch: The announcement comes as many European countries suspended the use of the AstraZeneca vaccine amid growing concerns that blood clots may be a possible side effect.

Covishield vaccination will go on with full vigour: India

The World Health Organisation (WHO) has listed two additional COVID-19 vaccines for emergency use which includes India's Covishield vaccine and the other one is produced by AstraZeneca.

WHO approves Covishield vaccine for emergency use

India on Thursday dispatched the first batch of home-grown Covishield vaccine consignments to Sri Lanka as a gift under the neighbourhood policy. Staff at an airport in Mumbai prepared boxes containing vaccines for shipment to Sri Lanka.

India sends 5,00,000 doses of Covishield vaccine to Sri Lanka

After the shipment of the Covishield Vaccines from India that reached Brazil, the health workers in Rio De Janeiro were among the very first people to be given the jab of a vaccine vial that was manufactured in India.

Brazil starts vaccination drive with Indian jab